Risk factors for recurrence in patients with uterine fibroids treated with high-intensity focused ultrasound

医学 子宫肌瘤 逻辑回归 单变量分析 妇科 怀孕 初潮 高强度聚焦超声 产科 超声波 多元分析 放射科 内科学 遗传学 生物
作者
Xiaoyan Bian,Xiaofeng Gu
出处
期刊:Technology and Health Care [IOS Press]
卷期号:33 (2): 945-950
标识
DOI:10.1177/09287329241291362
摘要

Background Uterine fibroids, benign smooth muscle tumors prevalent in the female genital tract, affecting up to 40% of women of childbearing age. High-intensity focused ultrasound (HIFU) has emerged as a promising non-invasive approach for treating uterine fibroids, but some patients may still experience recurrence of uterine fibroids after treatment. Objective This study aims to explore the risk factors associated with uterine fibroid recurrence following HIFU treatment, and to provide a basis for formulating response measures to prevent uterine fibroid recurrence after surgery in clinical practice. Methods In this regression observational study, 120 patients with uterine fibroids who underwent HIFU therapy at our institution from Jan 2018 to Dec 2021 were included as the study subjects. Collect clinical data of all included patients, and follow up for a total of 2 years every 6 menstrual periods with gynecological ultrasound or related examinations after surgery. Univariate and logistic regression analyses were performed to identify risk factors for recurrence in potential uterine fibroid patients receiving HIFU knife treatment. Results Patients were divided into a relapse group (n = 27) and a non-relapse group (n = 93) based on recurrence during the follow-up period. The outcome of univariate analysis indicated no statistically significant difference in age, BMI, age at menarche, history of preoperative pregnancy, history of postoperative pregnancy, family history of uterine fibroids, Bcl-2, FSH, LH, E2, PRL, P, and T between the two groups ( p > 0.05). Notably, significant differences were observed in fibroid diameter, ER, and PR ( p < 0.05). Logistic regression analysis revealed uterine fibroid diameter (OR = 28.032, 6.074 ∼ 129.372), PR (OR = 4.642, 2.382 ∼ 9.049), and ER (OR = 3.435, 1.820 ∼ 6.483) were independent risk factors for uterine fibroid recurrence after HIFU knife treatment. ROC curve analysis showed that the AUC of uterine fibroid recurrence predicted by fibroid diameter, ER, and PR after HIFU knife treatment were 0.791, 0.738, and 0.785, respectively. Conclusion The diameter, ER, and PR of uterine fibroids are closely related to the recurrence of uterine fibroids after surgical treatment, and it is worth implementing key perioperative management in clinical practice to prevent and manage the recurrence of uterine fibroids.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
123完成签到 ,获得积分10
刚刚
sui完成签到,获得积分10
刚刚
真不懂了嗷完成签到 ,获得积分10
1秒前
牛的兄弟发布了新的文献求助10
3秒前
4秒前
量子星尘发布了新的文献求助10
4秒前
小橙完成签到 ,获得积分10
5秒前
6秒前
orixero应助活泼苑博采纳,获得10
7秒前
科研通AI6.1应助逐梦采纳,获得10
8秒前
8秒前
佳jia发布了新的文献求助10
9秒前
科研通AI6.1应助高天雨采纳,获得10
11秒前
李爱国应助吴佳琪采纳,获得10
11秒前
无花果应助碧蓝之柔采纳,获得10
11秒前
LT发布了新的文献求助10
11秒前
12秒前
Wri完成签到,获得积分10
14秒前
量子星尘发布了新的文献求助10
15秒前
Wri发布了新的文献求助10
17秒前
2627完成签到,获得积分10
18秒前
19秒前
Orange应助wwlllzzttt采纳,获得10
19秒前
19秒前
清秀小霸王完成签到 ,获得积分10
20秒前
隐形曼青应助冷傲雪糕采纳,获得10
21秒前
21秒前
小蘑菇应助jack采纳,获得10
23秒前
科研通AI6.1应助lanxinyue采纳,获得10
23秒前
华123应助难过盼海采纳,获得10
24秒前
25秒前
25秒前
量子星尘发布了新的文献求助10
26秒前
26秒前
tmrrrrrr完成签到,获得积分10
29秒前
30秒前
小二郎应助11采纳,获得10
31秒前
爱说实话发布了新的文献求助10
31秒前
无情颖发布了新的文献求助10
33秒前
kewy完成签到,获得积分10
34秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Forensic and Legal Medicine Third Edition 5000
Introduction to strong mixing conditions volume 1-3 5000
Agyptische Geschichte der 21.30. Dynastie 3000
Aerospace Engineering Education During the First Century of Flight 2000
„Semitische Wissenschaften“? 1510
从k到英国情人 1500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5770023
求助须知:如何正确求助?哪些是违规求助? 5582550
关于积分的说明 15423156
捐赠科研通 4903584
什么是DOI,文献DOI怎么找? 2638255
邀请新用户注册赠送积分活动 1586124
关于科研通互助平台的介绍 1541285